Association between dietary heterocyclic amine levels, genetic polymorphisms of NAT2, CYP1A1, and CYP1A2 and risk of colorectal cancer: A hospital-based case-control study in Japan

Minatsu Kobayashi Epidemiology and Prevention Division, Research Center for Cancer Prevention and Screening, National Cancer Center, Tokyo, Japan; Department of Food Science, Faculty of Home Economics, Otsuma Women's University, Tokyo, JapanCorrespondence[email protected]

Tetsuya Otani Epidemiology and Prevention Division, Research Center for Cancer Prevention and Screening, National Cancer Center, Tokyo, Japan

Motoki Iwasaki Epidemiology and Prevention Division, Research Center for Cancer Prevention and Screening, National Cancer Center, Tokyo, Japan

Shusuke Natsukawa Saku Central Hospital, Nagano, Japan

Kozo Shaura Hokushin General Hospital, Nagano, Japan

Yoichi Koizumi Shinonoi General Hospital, Nagano, Japan

Yoshio Kasuga Nagano Matsushiro General Hospital, Nagano, Japan

Hiromi Sakamoto Genetic Division, National Cancer Center Institute, Tokyo, Japan

Teruhiko Yoshida Genetic Division, National Cancer Center Institute, Tokyo, Japan

Shoichiro Tsugane Epidemiology and Prevention Division, Research Center for Cancer Prevention and Screening, National Cancer Center, Tokyo, Japan

show all

Association between dietary heterocyclic amine levels, genetic polymorphisms of NAT2, CYP1A1, and CYP1A2 and risk of colorectal cancer: A hospital-based case-control study in Japan

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Association between dietary heterocyclic amine levels, genetic polymorphisms of NAT2, CYP1A1, and CYP1A2 and risk of colorectal cancer: A hospital-based case-control study in Japan

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date